top of page
FEATURED
Front Row Lecture - Scripps Research Magazine
Front Row Lecture - Scripps Research Magazine
In The Spotlight:
Exploring the Brain: Insights from Neuroscientist Catherine Lopez
From Puzzles to Biopsychology: Meet Allison White
Breaking Barriers in Science: Meet Dr. Francisco Flores-Ramirez
CHLOE ERIKSON
Molecular Medicine
KIERA FLECK
Molecular Medicine
Congratulations to Dr. Francisco Flores Ramirez for winning the 1st Place Award for Best Talk at the 2024 SYMPOSIUM AND LUNCHEON UNDERSCORING DIVERSITY IN BIOLOGICAL SCIENCE
Talk Title:
LY2444296, a kappa-opioid receptor antagonist, selectively reduces alcohol drinking in male and female Wistar rats with a history of alcohol dependence
Featured Publications:
 "Researchers pinpoint brain cells that delay first bite of food"July 2024 A set of neurons identified by Scripps Research scientists influence the start of eating and drinking. |  "Researchers identify brain region involved in oxycodone relapse."July 2024 Study by Scripps Research scientists suggests future therapies for opioid and alcohol addiction. |  "How Neural Inhibition Could Reduce Alcohol Use"March 2024 A Scripps Research team shows that suppressing the activity of certain stress neurons may decrease alcohol use—but not anxiety—in comorbid cases of post-traumatic stress disorder and alcohol use disorder. |  "How Blocking a Neural Receptor Responsible for Addiction Could Reduce Alcohol Use"March 2024 A Scripps Research team found that a new therapeutic that targets the kappa opioid receptor in the brain may reduce alcohol dependence. |
|---|---|---|---|
 "Scripps Research scientists give new insight into a molecular target of alcohol"January 2024 By investigating a molecule in the brain tied to cellular communication, scientists uncover important information about the proteins that do—and do not—influence alcohol drinking behavior. |  "Insomnia drug helps prevent oxycodone relapse, Scripps Research study shows"September 2023 New findings suggest that treating insomnia can stop opioid-seeking behavior, even after ending treatment. |  "Blocking glutamate release reduces oxycodone intake and seeking behavior"July 2023 In a preclinical study, Scripps Research scientists show that the drug ADX106772 (Addex Therapeutics) reduced oxycodone intake and relapse, without disrupting the brain’s natural reward system. |  "Excessive alcohol consumption may accelerate Alzheimer’s disease progression"June 2023 Scripps Research and University of Bologna scientists showed how excessive alcohol consumption in animals can hasten cognitive decline in those genetically predisposed to Alzheimer’s disease. |
bottom of page